PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

Posted by on May 29th, 2026

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the target of a large increase in short interest in May. As of May 15th, there was short interest totaling 51,769 shares, an increase of 1,271.7% from the April 30th total of 3,774 shares. Based on an average daily volume of 347,170 shares, the days-to-cover ratio is presently 0.1 days.

PharmaTher Stock Down 0.9%

OTCMKTS:PHRRF traded down $0.00 on Friday, reaching $0.05. 22,225 shares of the stock traded hands, compared to its average volume of 179,611. PharmaTher has a 12 month low of $0.04 and a 12 month high of $0.55. The company’s fifty day simple moving average is $0.05 and its 200 day simple moving average is $0.07.

About PharmaTher

(Get Free Report)

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.

Featured Articles

Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.